# The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients

> **NCT00798590** · PHASE2 · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 19 (actual)

## Conditions studied

- Critically Ill
- Hypoglycemia

## Interventions

- **DRUG:** Glucagon-Like Peptide-1
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT00798590
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-12
- **Primary completion:** 2010-06
- **Final completion:** 2011-06
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** PI left JHU
- **Last updated:** 2017-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00798590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00798590, "The Efficacy of Glucagon Like Peptide (GLP) - 1(7-36) Amide for Glycemic Control in Critically Ill Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00798590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*